Related Experiment Video
Updated: May 25, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Update on gestational diabetes mellitus
1Department of Family Medicine, University of Wisconsin School of Medicine and Public Health, 100 North Nine Mound Road, Verona, WI 53593, USA. ann.evensen@uwmf.wisc.edu
Primary Care
|February 8, 2012
Summary
Gestational diabetes mellitus (GDM) is rising, and while its treatment is beneficial, evidence for universal screening is limited. Postpartum screening 6 weeks after delivery is recommended using a glucose tolerance test.
Area of Science:
- Obstetrics and Gynecology
- Endocrinology
- Public Health
Background:
- Increasing incidence of gestational diabetes mellitus (GDM) in the United States.
- Universal GDM screening is recommended, but supporting evidence is lacking.
- GDM treatment effectively reduces risks of shoulder dystocia, preeclampsia, and macrosomia.
Purpose of the Study:
- To review the current landscape of gestational diabetes mellitus (GDM) management.
- To discuss the efficacy of different treatment intensities and modalities.
- To provide recommendations for postpartum screening.
Main Methods:
- Literature review of GDM screening, treatment, and management guidelines.
- Analysis of evidence regarding the safety and efficacy of metformin and glyburide.
- Evaluation of postpartum screening methods.
Main Results:
- Intensive GDM treatment is more effective than less-intensive approaches.
- Traditional management involves diet, exercise, and insulin.
- Accumulating evidence supports the safety and efficacy of metformin and glyburide.
- Postpartum glucose tolerance testing is preferred over fasting blood glucose levels.
Conclusions:
- Treatment of GDM is crucial for reducing adverse maternal and neonatal outcomes.
- While universal screening lacks strong evidence, treatment benefits are clear.
- Metformin and glyburide show promise as alternative or adjunct therapies.
- Standardized postpartum screening is essential for long-term maternal health.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...